The Lancet Global Health Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov model  Jianjun Tang, PhD, Prof Yuanbo Liang, MD, Prof Ciaran O'Neill, PhD, Prof Frank Kee, MD, Junhong Jiang, MD, Prof Nathan Congdon, MD  The Lancet Global Health  DOI: 10.1016/S2214-109X(19)30201-3 Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions

Figure Deterministic one-way sensitivity analysis Costs are given in US dollars. Analysis is done on the five parameters that caused the largest changes to the ICUR in each screening combination in different settings. The intervention was defined as cost-effective if it cost less than $12 030 in rural areas (per-capita GDP $4010) and less than $32 000 in urban areas (per-capita GDP $10 800). GDP=gross domestic product. ICUR=incremental cost-utility ratio. PAC=primary angle closure. PACG=PAC glaucoma. POAG=primary open angle glaucoma. The Lancet Global Health DOI: (10.1016/S2214-109X(19)30201-3) Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions